Impact of Double J Catheter in Major Urological Complications in Renal Transplant Recipients

Impact on Major Urologic Complications With Prophylactic Use of Double J Catheter in Extravesical Ureteroneocystostomy in Renal Transplant Recipients

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07008131

Enrollment

Registered

2025-06-06

Start date

2022-01-01

Completion date

2023-12-31

Last updated

2025-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Double J Stent, Kidney Transplant, Urinary Complications

Keywords

Kidney Transplant, Urinary Complications, Double J stent

Brief summary

Renal transplantation is the renal replacement therapy of choice in patients with end-stage chronic kidney disease. Major urological complications such as urinary leakage, ureteral stricture and urinary tract infections are usually observed in the first three months post-transplantation and lead to higher morbidity and mortality and lower graft function. To evaluate the use of the double J catheter on major urological complications in extravesical ureteroneocystostomy in renal recipients. Open clinical trial. Renal transplant recipients were included, who underwent extravesical ureteroneocystostomy with trans-surgical placement of double J catheter compared to extravesical ureteroneocystostomy without trans-surgical catheter placement. The study variables were urinary leakage, ureteral stricture, urinary tract infection, surgical complications and graft function.

Interventions

DEVICEDouble J stent

Extravesical ureteroneocystostomy with double J-catheter placement

PROCEDURENo Double J stent

Extravesical ureteroneocystostomy with no Double J stent colocation

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* 18 years or older * Renal transplantation candidates * They agree to participate in the study

Exclusion criteria

* Previous renal transplantation * Urinary tract malformations * Urinary reservoir carriers * Known neurogenic disease of the urinary tract * Cadaveric donor grafts * Grafts with double collecting system * Patients whose trans-surgical findings require catheter placement.

Design outcomes

Primary

Measure	Time frame	Description
Major urological complications	From enrollment to three months	Urinary leakage, uretheral stenosis and urinary infection

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026